Filing Details
- Accession Number:
- 0001127602-12-008164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-27 17:44:22
- Reporting Period:
- 2012-02-23
- Filing Date:
- 2012-02-27
- Accepted Time:
- 2012-02-27 17:44:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1097264 | Allos Therapeutics Inc | ALTH | Pharmaceutical Preparations (2834) | 541655029 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202769 | L Paul Berns | 11080 Circlepoint Road Suite 200 Westminster CO 80020 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-23 | 9,100 | $1.56 | 706,862 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-24 | 4,350 | $1.55 | 702,512 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares are being sold pursuant to a 10b5-1 plan for Paul L. Berns in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 22, 2012.
- These shares are being sold pursuant to a 10b5-1 plan for Paul L. Berns in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 23, 2012.